Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Avacta offers solutions to industrial technology shortfalls

02.11.2004


A new company has been spun out of the University of Leeds to develop enabling technologies based on its innovative and world leading analytical science base.



Avacta Ltd has a strong background in the development of novel technologies applicable to the biomedical, materials and nanotechnology sectors and is focused on developing solutions to technology shortfalls in the biotech, pharmaceutical and healthcare sectors.

Spun out by Techtran Group Ltd – the University’s commercialisation partner, Avacta is supporting these IP generation activities by providing one of the most comprehensive in-house analytical services in the world. Avacta provides industry with access to Leeds and other regional Universities’ state of the art physical and chemical analytical infrastructure and a complete project management package from problem identification through to choice of technical solution and implementation.


Avacta is headed by Dr Alastair Smith from the School of Physics and Astronomy at the University of Leeds, together with fellow directors Dr Simon Webster, Dr Kurt Baldwin and Alan Brain.

Together they have extensive industrial experience and a strong track record in the development of enabling technologies and the provision of analytical services to industry and in pharmaceutical patent litigation processes. In addition to providing a comprehensive analytical service, the company’s combined skills in optical and spectroscopic instrumentation design enables Avacta to provide expert design and implementation of quality and process control solutions.

Dr Smith’s background in molecular biophysics has established in-house R&D programmes aimed at tackling key problems which face the pharmaceutical industries such as how to conduct high throughput testing of membrane proteins which are major drug targets but difficult to handle in a conventional biochip approach due to their insolubility. Avacta is also working on ways of pushing detection technologies to the ultimate limit of single molecule sensitivity and new approaches to high throughput assays without the need for time consuming and costly fluorescent labelling.

Dr Smith said “Avacta’s approach to supporting a strong and innovative R&D programme through its analytical services and technical consultancy activities has provided us with a sound basis for growth and a tremendously exciting outlook”.

Techtran Investment manager, Dr Alex Stevenson said: “Avacta is focusing on developing new products and services for market areas with significant growth potential and the founders have an outstanding track record of delivery. We look forward to working with the management team to grow the business. ”

Dr Alex Stevenson | alfa
Further information:
http://www.techtrangroup.com

More articles from Life Sciences:

nachricht The body's street sweepers
18.12.2017 | Ludwig-Maximilians-Universität München

nachricht Life on the edge prepares plants for climate change
18.12.2017 | Max-Planck-Institut für Entwicklungsbiologie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Error-free into the Quantum Computer Age

A study carried out by an international team of researchers and published in the journal Physical Review X shows that ion-trap technologies available today are suitable for building large-scale quantum computers. The scientists introduce trapped-ion quantum error correction protocols that detect and correct processing errors.

In order to reach their full potential, today’s quantum computer prototypes have to meet specific criteria: First, they have to be made bigger, which means...

Im Focus: Search for planets with Carmenes successful

German and Spanish researchers plan, build and use modern spectrograph

Since 2016, German and Spanish researchers, among them scientists from the University of Göttingen, have been hunting for exoplanets with the “Carmenes”...

Im Focus: First-of-its-kind chemical oscillator offers new level of molecular control

DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.

Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

The body's street sweepers

18.12.2017 | Life Sciences

Fast flowing heat in layered material heterostructures

18.12.2017 | Materials Sciences

Life on the edge prepares plants for climate change

18.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>